AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
182.36
+0.59 (0.32%)
Dec 3, 2024, 2:04 PM EST - Market open

AbbVie Operating Expense Breakdown

History

Date Selling, General, and Administrative Research and Development Acquired In-Process R&D Other
Sep 29, 202414.09B7.94B1.47B-
Jun 29, 202413.26B7.54B1.45B-
Mar 31, 202413.15B7.32B792.00M-
Dec 31, 202312.87B7.68B778.00M-
Sep 29, 202313.10B7.54B739.00M-
Jun 29, 202313.03B7.43B713.00M49.00M
Mar 30, 202315.17B7.31B702.00M46.00M
Dec 31, 202215.26B6.51B697.00M56.00M
Sep 29, 202215.10B6.55B859.00M57.00M
Jun 29, 202214.88B6.59B1.22B328.00M
Mar 30, 202212.63B6.75B1.08B-
Dec 31, 202112.35B6.92B1.12B-
Sep 29, 202112.32B6.99B1.02B432.00M
Jun 29, 202112.08B7.03B662.00M-68.00M
Mar 30, 202112.45B6.85B1.38B-
Dec 31, 202011.30B6.56B1.20B-
Sep 29, 202010.02B6.21B1.04B-
Jun 29, 20208.83B6.79B992.00M-
Mar 30, 20206.96B6.50B--
Dec 31, 20196.94B6.41B385.00M-890.00M
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.